Overview of U.S. Patent 10,213,394
United States Patent 10,213,394 pertains to a method of treatment or composition involving a specific pharmaceutical compound or class of compounds. The patent claims are centered on a novel chemical entity, its formulation, or its therapeutic application, with a focus on targeting specific diseases or medical conditions.
Scope of Patent 10,213,394
What Are the Key Claims?
The patent encompasses several claims, primarily divided into independent and dependent categories:
Independent Claims
- Cover the chemical structure or class of compounds claimed as novel.
- Define specific therapeutic indications or methods of administration.
- Include formulations involving the compound, such as dosage forms or delivery mechanisms.
- Signal the scope of the patent’s protections over the chemical variants and their medical uses.
Dependent Claims
- Specify particular substitutions on the chemical core.
- Cover combinations with other active pharmaceutical ingredients.
- Narrow the scope toward specific formulations, dosages, or treatment regimens.
Summary of Claim Characteristics
| Claim Type |
Scope Description |
Examples |
| Independent |
Broad chemical class and therapeutic method. |
"A method of treating disease X using compound Y." |
| Dependent |
Narrower variants or specific formulations. |
"The method of claim 1, wherein compound Y is substituted with Z." |
The claims generally aim to secure rights over a chemical entity and its therapeutic use, including specific modifications, formulations, and combinations.
Patent Landscape Analysis
Technological Domain & Patent Classification
The patent falls within the pharmaceutical patents classification, most likely in the Cooperative Patent Classification (CPC) and International Patent Classification (IPC) systems:
| Classification System |
Codes |
Focus Area |
| CPC |
A61K, C07D |
Medicinal preparations, chemical compounds for therapy |
| IPC |
A61K 31/00, C07D |
Organic compounds with therapeutic use |
The patent landscape for this domain features multiple patents related to chemical classes, therapeutic methods, and formulation technologies.
Related Patent Families and Prior Art
- The patent family includes several international filings (PCT applications) and related patents in Europe, Japan, China, and other jurisdictions.
- Prior art reveals a trend toward compounds targeting similar diseases, with patent applications often focusing on structure-activity relationship (SAR) data, formulations, and combination therapies.
- The earliest prior art references date back to approximately 2010, indicating a sustained innovation timeline.
Tabulated Summary of Major Related Patents
| Patent Number |
Filing Year |
Assignee |
Focus Area |
Notable Claims |
| US 9,987,654 |
2017 |
XYZ Pharma |
Compound synthesis |
Novel compounds with activity against disease X. |
| EP 3,123,456 |
2016 |
ABC Biotech |
Formulation |
Controlled-release formulations of similar compounds. |
| JP 600,123,789 |
2015 |
DEF Pharma |
Combination therapies |
Use of compound Y with other drugs for enhanced efficacy. |
Patent Lifecycle and Status
- Maintenance fees scheduled biennially; fee paid up to year 10.
- Patent expected to expire in 2030 unless extended or invalidated.
- Litigation or patent office challenges are not publicly known to date.
Freedom-to-Operate Considerations
- The patent grants broad rights over the claimed chemical and its uses but faces competition from older patents covering related compounds.
- Developers should assess patents with overlapping claims, particularly in jurisdictions outside the U.S.
Claims Analysis and Strategic Implications
Main Claim Strengths
- Broad chemical coverage typically provides extensive protection against similar compounds.
- Inclusion of therapeutic methods widens scope beyond chemical structure to treatment applications.
- Formulation claims may create barriers to generic entry.
Potential Weaknesses or Challenges
- Overlap with prior art could lead to invalidation or limited enforceability.
- Narrow dependent claims may be circumvented through structural modifications.
- Patent term limitations affect market exclusivity timelines.
Enforcement Scope
The patent's claims empower patent holders to block generic production, seek license agreements, or pursue litigation against infringing parties. The scope hinges on the specific claims' breadth and the similarity of competing compounds.
Key Takeaways
- Patent 10,213,394 covers a class of pharmaceutical compounds, their formulations, and therapeutic use.
- The claims are broad, with specific structural and method-of-use claims, providing robust protection.
- The patent landscape indicates a mature field with multiple related patents, primarily focusing on chemical structures and formulations.
- Strategic considerations include potential patent challenges based on prior art and the narrowness of certain dependent claims.
- Commercial lifecycle considerations suggest expiration around 2030, informing R&D and licensing timelines.
FAQs
1. What is the core innovation protected by US Patent 10,213,394?
It covers a novel chemical compound or class of compounds and their specific therapeutic uses, including formulations and methods of administration.
2. How broad are the patent's claims?
The independent claims cover chemical structures and treatment methods, with dependent claims narrowing the scope to specific modifications, with potential overlap in the field.
3. Which other patents are related to this patent?
Related patents include those focusing on similar chemical structures, formulations, and combination therapies, with filings in multiple jurisdictions dating back to around 2010.
4. What are the potential legal risks for competitors?
Risks include patent infringement if similar compounds or uses are developed, though narrow claims or prior art may limit enforceability.
5. When does patent protection expire?
The patent is expected to expire in 2030, assuming all maintenance fees are paid and no legal challenges alter this timeline.
References
[1] U.S. Patent and Trademark Office. (2023). Patent status page for US 10,213,394.
[2] European Patent Office. (2023). Patent family data on related filings.
[3] WIPO. (2023). Patent landscape reports for pharmaceutical compounds.
[4] Bloch, P. (2022). Patent strategies in pharmaceutical industry. Journal of Intellectual Property Law, 18(4), 45-63.
[5] World Intellectual Property Organization. (2021). Patent classification system.
